Temozolomide - HY-17364
Nur noch %1 verfügbar
Catalog #
HY-17364
Ab
39,00 €
Temozolomide (NSC 362856) is an oral active DNA alkylating agent that crosses the blood-brain barrier. Temozolomide is also a proautophagic and proapoptotic agent. Temozolomide is effective against tumor cells that are characterized by low levels of O6-alkylguanine DNA alkyltransferase (OGAT) and a functional mismatch repair system. Temozolomide has antitumor and antiangiogenic effects[1][2].
| Datasheet URL | http://file.medchemexpress.com/batch_PDF/HY-17364/Temozolomide-DataSheet-MedChemExpress.pdf |
|---|---|
| Shipping | Blue Ice |
| Application | Cancer-programmed cell death |
| Alternative Names | NSC 362856; CCRG 81045; TMZ |
| CAS | 85622-93-1 |
| Storage | -20°C (Powder, protect from light, stored under nitrogen) |
| MWT | 194.15 |
| Solubility | DMSO : 20.83 mg/mL (ultrasonic)|H2O : 2.86 mg/mL (ultrasonic) |
| Clinical Information | Launched |
| Target | Apoptosis;Autophagy;DNA Alkylator/Crosslinker |
| Application: | Cancer-programmed cell death |
|---|